Partial Epilepsy.: Unterschied zwischen den Versionen
K |
K |
||
| Zeile 1: | Zeile 1: | ||
| − | + | Prior to beginning SABRIL, tell your medical professional concerning all of your (or your kid's) medical conditions including clinical depression, mood troubles, suicidal thoughts [https://www.protopage.com/beunnaac6j Bookmarks] or actions, any allergy to SABRIL, vision issues, kidney problems, reduced red cell matters (anemia), and any nervous or psychological disease.<br><br>SABRIL (vigabatrin) is a prescription medicine used with other treatments in children and adults 2 years of age and older with refractory complicated partial seizures (CPS) who have not responded all right to several various other treatments and if the feasible advantages surpass the danger of vision loss. <br><br>It is advised that your doctor test your (or your child's) vision before or within 4 weeks after beginning SABRIL and at least every 3 months during therapy until SABRIL is quit. Inform your healthcare provider if you or your child have any type of adverse effects that bothers you or that does not go away.<br><br>Tell your healthcare provider if you are expecting or intend to obtain expecting. If vision testing can not be done, your doctor may continue suggesting SABRIL, but will not have the ability to expect any vision loss. Your healthcare company might quit recommending SABRIL for you (or your youngster)if vision tests are not done frequently. | |
Version vom 6. Mai 2024, 07:38 Uhr
Prior to beginning SABRIL, tell your medical professional concerning all of your (or your kid's) medical conditions including clinical depression, mood troubles, suicidal thoughts Bookmarks or actions, any allergy to SABRIL, vision issues, kidney problems, reduced red cell matters (anemia), and any nervous or psychological disease.
SABRIL (vigabatrin) is a prescription medicine used with other treatments in children and adults 2 years of age and older with refractory complicated partial seizures (CPS) who have not responded all right to several various other treatments and if the feasible advantages surpass the danger of vision loss.
It is advised that your doctor test your (or your child's) vision before or within 4 weeks after beginning SABRIL and at least every 3 months during therapy until SABRIL is quit. Inform your healthcare provider if you or your child have any type of adverse effects that bothers you or that does not go away.
Tell your healthcare provider if you are expecting or intend to obtain expecting. If vision testing can not be done, your doctor may continue suggesting SABRIL, but will not have the ability to expect any vision loss. Your healthcare company might quit recommending SABRIL for you (or your youngster)if vision tests are not done frequently.
